Theodore Kamenecka

Molecular mechanisms of stress hormone control of skeletal muscle metabolism

Preclinical development of a precision therapy for a monogenic mental health disorder

Ligand and transcriptional regulation of the nuclear receptor RORa on TH17 cell development and inflammation

Optimization of SR1903 and 10171

Mechanistic studies of corepressor-mediated PPAR? transcriptional repression

Molecular basis of activation of the orphan nuclear receptor Nurr1

Understanding the role of RORa in T-cell mediated colitis

Drug Discovery for First-In-Class Myosin 10 Inhibitors as a Novel Target for Glioblastoma

Demo batch scale-up of MT-125

Ligand-dependent regulation of the nuclear receptor REV-ERBa in TH17 cell development and inflammation

Small molecules targeting hepatic glucose production and insulin resistance

Targeting Go and Grow in Glioblastoma

Tissue Selective Glucocorticoids

Mitochondrial therapeutics for healthy brain aging

Molecular basis of activation of the orphan nuclear receptor Nurr1

Mitochondrial therapeutics for healthy brain aging

Identification of Chemical Probes for the Orphan Nuclear Receptor NR2F6

Identification of REV-ERB inverse agonists for cancer immunotherapy

Developing nonmuscle myosin II inhibitors for the treatment of glioblastoma

Drug Discovery for First-In-Class Myosin 10 Inhibitors as a Novel Target for Glioblastoma

Mechanistic studies of corepressor-mediated PPAR? transcriptional repression

ALDH1a1 Inhibition As A Therapeutic Target In Visceral Adiposity and Type 2 Diabetes

Development of novel therapeutics for opioid dependence

Optimization of SR1903 and SR10171

Parallel Multimodal High-throughput screening to identify activators of the orexin receptors